Targeting apoptosis in prostate cancer. [electronic resource]
Producer: 20020205Description: 509-24 p. digitalISSN:- 0889-8588
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspases -- physiology
- Cysteine Endopeptidases
- Cysteine Proteinase Inhibitors -- pharmacology
- Disease Progression
- Drug Design
- Drug Resistance, Neoplasm -- genetics
- Enzyme Inhibitors -- pharmacology
- Fas Ligand Protein
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, bcl-2
- Genes, p53
- Humans
- Interferons -- therapeutic use
- Male
- Membrane Glycoproteins -- physiology
- Mice
- Mice, Knockout
- Mitochondria -- physiology
- Multienzyme Complexes -- antagonists & inhibitors
- NF-kappa B -- physiology
- Neoplasm Proteins -- genetics
- Oligonucleotides, Antisense -- therapeutic use
- Phosphatidylinositol 3-Kinases -- physiology
- Phosphoinositide-3 Kinase Inhibitors
- Pilot Projects
- Prostatic Neoplasms -- drug therapy
- Proteasome Endopeptidase Complex
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt
- Proto-Oncogene Proteins c-bcl-2 -- physiology
- Retinoids -- therapeutic use
- Tumor Suppressor Protein p53 -- physiology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.